ZURICH, Jan 27 (Reuters) - Nestle on Monday said it is buying Allergan’s Zenpep to expand in medical nutrition with a product for people who cannot digest food properly because their pancreas does not provide enough enzymes to break down fat, protein, and carbohydrates.
Zenpep had sales of $237 million in 2018.
“This is a significant opportunity for our business in the United States to add a complementary product to our existing range of nutrition products that support food ingestion, digestion and absorption,” said Greg Behar, head of Nestle Health Science in a statement. (Reporting by John Miller Editing by Riham Alkousaa)
Our Standards: The Thomson Reuters Trust Principles.